Literature DB >> 17152419

Viscosupplementation in symptomatic severe hip osteoarthritis: a review of the literature and report on 60 patients.

Michel P J Van Den Bekerom1, Guy Mylle, Bart Rys, Michiel Mulier.   

Abstract

Osteoarthritis of the hip is a frequent joint disorder in adults aged 50 years and older. The management focuses on pain reduction, by means of non-steroidal anti-inflammatory drugs and analgesics, physical therapy and weight reduction. When these treatments fail, total hip replacement can be considered. Viscosupplementation is a local therapeutic approach with the objective to decrease pain and to improve joint mobility. The treatment consists of injecting hyaluronic acid or hyaluronate derivatives intra-articularly. Although this approach is frequently used in young sportive adults to avoid knee surgery, its use in the severe osteoarthritic hip is less well documented. Moreover the injection of the hip joint is more difficult than injection of the knee joint, and on another hand the general condition of the patients is often already compromised. In this article we present a literature review on the subject and report the results in 60 patients who received intraarticular viscosupplementation of the hip with the objective to delay total hip replacement surgery.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17152419

Source DB:  PubMed          Journal:  Acta Orthop Belg        ISSN: 0001-6462            Impact factor:   0.500


  6 in total

Review 1.  [Osteoarthritis: what internists should know].

Authors:  L Wildi
Journal:  Internist (Berl)       Date:  2015-05       Impact factor: 0.743

2.  Comparison of intra-articular injections of hyaluronic acid and corticosteroid in the treatment of osteoarthritis of the hip in comparison with intra-articular injections of bupivacaine. Design of a prospective, randomized, controlled study with blinding of the patients and outcome assessors.

Authors:  Sascha Colen; Michel P J van den Bekerom; Johan Bellemans; Michiel Mulier
Journal:  BMC Musculoskelet Disord       Date:  2010-11-16       Impact factor: 2.362

3.  [Pharmacological therapy of arthrosis].

Authors:  L M Wildi
Journal:  Z Rheumatol       Date:  2013-11       Impact factor: 1.372

Review 4.  Viscosupplementation for hip osteoarthritis: Does systematic review of patient-reported outcome measures support use?

Authors:  Alexander J Acuña; Linsen T Samuel; Stacy H Jeong; Ahmed K Emara; Atul F Kamath
Journal:  J Orthop       Date:  2020-03-25

5.  Use of Reticulated Hyaluronic Acid Alone or Associated With Ozone Gas in the Treatment of Osteoarthritis Due to Hip Dysplasia in Dogs.

Authors:  José I S Silva Júnior; Sheila C Rahal; Ivan F C Santos; David J C Martins; Fernanda Michelon; Maria J Mamprim; Rubia M Tomacheuski; Luiz E C S Correia
Journal:  Front Vet Sci       Date:  2020-05-13

6.  Significant synovial pathology in a meniscectomy model of osteoarthritis: modification by intra-articular hyaluronan therapy.

Authors:  M M Smith; M A Cake; P Ghosh; A Schiavinato; R A Read; C B Little
Journal:  Rheumatology (Oxford)       Date:  2008-06-19       Impact factor: 7.580

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.